330 related articles for article (PubMed ID: 19833956)
21. New developments in the treatment of Alzheimer's disease.
J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
[No Abstract] [Full Text] [Related]
22. [Search of biological markers of Alzheimer's disease].
Couderc R
Ann Biol Clin (Paris); 2000; 58(5):581-93. PubMed ID: 11022101
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.
Buerger K; Ewers M; Andreasen N; Zinkowski R; Ishiguro K; Vanmechelen E; Teipel SJ; Graz C; Blennow K; Hampel H
Neurology; 2005 Nov; 65(9):1502-3. PubMed ID: 16275849
[No Abstract] [Full Text] [Related]
24. [Biomarkers in cerebrospinal fluid and blood in memory complaints].
Zetterberg H; Andreasen N; Blennow K
Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836
[No Abstract] [Full Text] [Related]
25. Biomarkers in Alzheimer's disease.
Lovestone S
J Nutr Health Aging; 2006; 10(2):118-22. PubMed ID: 16554945
[No Abstract] [Full Text] [Related]
26. Shunting for Alzheimer's disease: stymied by a different sort of placebo effect?
Carter BS
Neurosurgery; 2008 Oct; 63(4):N11. PubMed ID: 18981866
[No Abstract] [Full Text] [Related]
27. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
Taniguchi M; Okayama Y; Hashimoto Y; Kitaura M; Jimbo D; Wakutani Y; Wada-Isoe K; Nakashima K; Akatsu H; Furukawa K; Arai H; Urakami K
Dement Geriatr Cogn Disord; 2008; 26(2):117-22. PubMed ID: 18654083
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease neuroimaging initiative in Europe.
Frisoni GB
Alzheimers Dement; 2010 May; 6(3):280-5. PubMed ID: 20451877
[TBL] [Abstract][Full Text] [Related]
29. Diagnosing Alzheimer's: low tech & high tech.
Johns Hopkins Med Lett Health After 50; 2004 Jun; 17(4):4. PubMed ID: 15199886
[No Abstract] [Full Text] [Related]
30. [The value of new diagnostic techniques in Alzheimer's disease].
Scheltens P; Weinstein HC; van Gool WA
Ned Tijdschr Geneeskd; 1992 Dec; 136(50):2459-62. PubMed ID: 1465167
[No Abstract] [Full Text] [Related]
31. Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report.
Ibach B; Haen E; Marienhagen J; Hajak G
Pharmacopsychiatry; 2005 Jul; 38(4):178-9. PubMed ID: 16025421
[TBL] [Abstract][Full Text] [Related]
32. Neuroscience. A better view of brain disorders.
Miller G
Science; 2006 Sep; 313(5792):1376-9. PubMed ID: 16959984
[No Abstract] [Full Text] [Related]
33. Diagnostic biomarker for early stage of Alzheimer's disease: current state and view in the future.
Urakami K
Psychogeriatrics; 2010 Jun; 10(2):49-52. PubMed ID: 20738807
[No Abstract] [Full Text] [Related]
34. [Recent study on Alzheimer's disease].
Hirai S
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):367-71. PubMed ID: 8315330
[No Abstract] [Full Text] [Related]
35. Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.
Shi J
Neurology; 2007 Sep; 69(10):1063-4; author reply 1064-5. PubMed ID: 17785679
[No Abstract] [Full Text] [Related]
36. [Clinical aspects of Alzheimer's disease].
Namba Y
Nihon Rinsho; 2004 Jan; 62 Suppl():61-5. PubMed ID: 15011321
[No Abstract] [Full Text] [Related]
37. No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Alafuzoff I; Ewers M; Pirttilä T; Zinkowski R; Hampel H
Brain; 2007 Oct; 130(Pt 10):e82. PubMed ID: 17615094
[No Abstract] [Full Text] [Related]
38. Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties.
Marksteiner J; Pirchl M; Ullrich C; Oberbauer H; Blasko I; Lederer W; Hinterhuber H; Humpel C
Pharmacology; 2008; 82(3):214-20. PubMed ID: 18810245
[TBL] [Abstract][Full Text] [Related]
39. Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies.
Seibyl J; Zubal IG; Jennings D; Marek K; Doraiswamy PM
Expert Rev Neurother; 2011 Dec; 11(12):1783-93. PubMed ID: 22091601
[TBL] [Abstract][Full Text] [Related]
40. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor.
Haes AJ; Chang L; Klein WL; Van Duyne RP
J Am Chem Soc; 2005 Feb; 127(7):2264-71. PubMed ID: 15713105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
